Watson, R., Tong, O., Taylor, C., Kumar Sharma, P., Verge De Los Aires, A., Mahe, E., . . . Fairfax, B. (2021). Immune Checkpoint Blockade sensitivity and Progression-Free Survival associates with baseline CD8+ T cell clone size and cytotoxicity. bioRxiv.
Chicago-referens (17:e uppl.)Watson, R., et al. Immune Checkpoint Blockade Sensitivity and Progression-Free Survival Associates with Baseline CD8+ T Cell Clone Size and Cytotoxicity. bioRxiv, 2021.
MLA-referens (9:e uppl.)Watson, R., et al. Immune Checkpoint Blockade Sensitivity and Progression-Free Survival Associates with Baseline CD8+ T Cell Clone Size and Cytotoxicity. bioRxiv, 2021.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.